Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics

BACKGROUND: The use of tumour xenografts is a well-established research tool in cancer genomics but has not yet been comprehensively evaluated for cancer epigenomics. METHODS: In this study, we assessed the suitability of patient-derived tumour xenografts (PDXs) for methylome analysis using Infinium...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Genome Med
Main Authors: Guilhamon, Paul, Butcher, Lee M, Presneau, Nadege, Wilson, Gareth A, Feber, Andrew, Paul, Dirk S, Schütte, Moritz, Haybaeck, Johannes, Keilholz, Ulrich, Hoffman, Jens, Ross, Mark T, Flanagan, Adrienne M, Beck, Stephan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292812/
https://ncbi.nlm.nih.gov/pubmed/25587359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-014-0116-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados